English
Investors
Shareholders
EQT logo
About
Teams
Sustainability
Investments
Media
Important notice
Current portfolio
FoRx Therapeutics
oRx Therapeutics focuses on drugging key molecular targets involved in the DNA Replication Stress as a new approach in the developments.
Sector
Healthcare
Country
Switzerland
Fund
LSP 6
Entry
2019
Web
forxtherapeutics.com
Sector
Healthcare
Country
Switzerland
Fund
LSP 6
Entry
2019
Web
forxtherapeutics.com
0
Investments
EQT logo